You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCM

Showing 1 - 25 of 223
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertrophic Cardiomyopathy Trial in London (Asynchronous dual chamber pacing (DOO) with paced ventricular activation,

Active, not recruiting
  • Hypertrophic Cardiomyopathy
  • Asynchronous dual chamber pacing (DOO) with paced ventricular activation
  • Asynchronous atrial pacing (AOO) with intrinsic ventricular activation
  • London, Thames, United Kingdom
    Barts Heart Centre
Sep 30, 2022

Patients' Long-Term Survival of Obstructive Hypertrophic

Completed
  • Cardiomyopathy
  • Obstructive Hypertrophic Cardiomyopathy
    • Bethesda, Maryland
      National Heart, Lung and Blood Institute (NHLBI)
    May 27, 2022

    Hypertrophic Cardiomyopathy Trial in London (Exercise)

    Completed
    • Hypertrophic Cardiomyopathy
    • Exercise
    • London, United Kingdom
    • +2 more
    Jul 12, 2022

    Hypertrophic Cardiomyopathy Trial in San Francisco (Moderate Intensity Exercise Program)

    Recruiting
    • Hypertrophic Cardiomyopathy
    • Moderate Intensity Exercise Program
    • San Francisco, California
      University of California - San Francisco
    Apr 5, 2023

    Hypertrophic Cardiomyopathy Trial in United States (TN-201)

    Not yet recruiting
    • Hypertrophic Cardiomyopathy
    • TN-201
    • Boston, Massachusetts
    • +6 more
    Apr 18, 2023

    Differentiating Hypertrophic Cardiomyopathy From Hypertensive

    Completed
    • Hypertrophic Cardiomyopathy
    • Hypertensive Heart Disease
    • evaluated by the predetermined differentiating formula
    • Shanghai, China
      Renji Hospital
    Nov 14, 2022

    Obstructive Hypertrophic Cardiomyopathy Trial in Boston, Kansas City, Omaha

    Not yet recruiting
    • Obstructive Hypertrophic Cardiomyopathy
      • (no location specified)
      Aug 3, 2022

      Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)

      Recruiting
      • Hypertrophic Cardiomyopathy
        • Rochester, Minnesota
          Mayo Clinic
        Jul 1, 2022

        Hypertrophic Cardiomyopathy Trial in Houston (N-acetylcysteine, Placebo)

        Completed
        Has Results
        • Hypertrophic Cardiomyopathy
        • Houston, Texas
          The University of Texas Health Science Center at Houston
        Nov 1, 2021

        Hypertrophic Cardiomyopathy Trial in Dallas (High intensity exercise, Moderate intensity exercise)

        Active, not recruiting
        • Hypertrophic Cardiomyopathy
        • High intensity exercise
        • Moderate intensity exercise
        • Dallas, Texas
          The Institute for Exercise and Environmental Medicine
        Aug 23, 2022

        Symptomatic Hypertrophic Cardiomyopathy (HCM) Trial in Italy, Spain, United States (CK-3773274 (5 - 20 mg))

        Enrolling by invitation
        • Symptomatic Hypertrophic Cardiomyopathy (HCM)
        • CK-3773274 (5 - 20 mg)
        • Los Angeles, California
        • +18 more
        Jan 31, 2023

        Hypertrophic Cardiomyopathy, Mechanical Hyper-synchronicity Trial in Bordeaux (Echocardiography (TEE), Magnetic resonance

        Completed
        • Hypertrophic Cardiomyopathy
        • Mechanical Hyper-synchronicity
        • Echocardiography (TEE)
        • +3 more
        • Bordeaux, France
          CHU de Bordeaux
        Feb 8, 2022

        Functional Capacity and Quality of Life Following Septal

        Recruiting
        • Hypertrophic Cardiomyopathy
          • Cleveland, Ohio
            Cleveland Clinic
          May 3, 2022

          Cardiomyopathies Trial in Warsaw (ECG, 24-hour ECG monitoring, Cardio-pulmonary exercise test (CPET))

          Active, not recruiting
          • Cardiomyopathies
          • ECG
          • +3 more
          • Warsaw, Poland
            Medical Univeristy of Warsaw
          Aug 17, 2022

          UTSW HP [13-C] Pyruvate Injection in HCM

          Suspended
          • Cardiomyopathy, Hypertrophic
          • Hyperpolarized 13C-Pyruvate
          • Dallas, Texas
            UT Southwestern Medical Center - Advanced Imaging Research Cente
          Mar 8, 2022

          Hypertrophic Cardiomyopathy (HCM) Trial in Worldwide (CK-3773274 (5 - 15 mg), CK-3773274 (10 - 30 mg), Placebo for CK-3773274)

          Recruiting
          • Hypertrophic Cardiomyopathy (HCM)
          • CK-3773274 (5 - 15 mg)
          • +2 more
          • Los Angeles, California
          • +21 more
          Mar 4, 2022

          Hypertrophic Cardiomyopathy, Hypertrophic Obstructive Cardiomyopathy, Familial Hypertrophic Cardiomyopathy Trial in Canada

          Enrolling by invitation
          • Hypertrophic Cardiomyopathy
          • +3 more
            • Calgary, Alberta, Canada
            • +10 more
            Oct 17, 2022

            Rotavirus, Diarrhea Trial in Ho Chi Minh (Rotarix vaccine)

            Completed
            • Rotavirus
            • Diarrhea
            • Rotarix vaccine
            • Ho Chi Minh, Vietnam
              Hung Vuong Hospital
            Nov 10, 2022

            Hypertrophic Cardiomyopathy, Obstructive Hypertrophic Cardiomyopathy, Non-obstructive Hypertrophic Cardiomyopathy Trial in

            Active, not recruiting
            • Hypertrophic Cardiomyopathy
            • +2 more
            • Scottsdale, Arizona
            • +68 more
            Sep 20, 2022

            Sudden Cardiac Arrest, Sudden Arrhythmic Death Syndrome, Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Trial in

            Enrolling by invitation
            • Sudden Cardiac Arrest
            • +5 more
              • Vancouver, British Columbia, Canada
                University of British Columbia/St. Paul's Hospital
              Oct 31, 2022

              Obstructive Hypertrophic Cardiomyopathy Trial in Beijing (Mavacamten, Placebo)

              Recruiting
              • Obstructive Hypertrophic Cardiomyopathy
              • Beijing, Beijing, China
                Peking Union Medical College Hospital
              Jan 17, 2022

              Inherited Cardiac Arrythmias, Long QT Syndrome (LQTS), Brugada Syndrome (BrS) Trial in Baltimore

              Enrolling by invitation
              • Inherited Cardiac Arrythmias
              • +9 more
                • Baltimore, Maryland
                  Johns Hopkins Medical Institute
                Jan 5, 2023

                CVD Risk Profile in Children With HCM

                Recruiting
                • Hypertrophic Cardiomyopathy
                  • Edmonton, Alberta, Canada
                  • +9 more
                  Aug 18, 2022

                  Hypertrophic Cardiomyopathy Trial in Adelaide (Perhexiline, Placebo)

                  Recruiting
                  • Hypertrophic Cardiomyopathy
                  • Adelaide, South Australia, Australia
                    Flinders Medical Centre
                  Mar 9, 2021

                  Patients With Hypertrophic Cardiomyopathy

                  Recruiting
                  • HCM - Hypertrophic Cardiomyopathy
                  • No intervention nor exposure
                  • Guangzhou, Guangdong, China
                    Guangdong cardiovascular institute
                  Apr 17, 2021